Medical Marijuana in Pennsylvania | 1.1 contact hour

$10.00

NOTE: This course will not fulfill the state’s requirements for practitioners and medical professionals to obtain medical marijuana certification. The state-approved education is on the CE Center site and is titled “Medical Marijuana: A Course for Practitioners.” 

About this Article:

Pennsylvania’s Medical Marijuana Act legalized the use of medical marijuana as an alternative therapeutic to ease suffering and improve the quality of life in patients who are terminally ill or suffer from a serious medical condition. Lack of valid and reliable research has inhibited the development of evidence-based recommendations. There are ethical concerns regarding generated financial revenue, consumer access, and safety. Legal conflict exists with federal statutes impacting all stages of growth, processing, distribution, and use, as well as enforcement, banking, and employment regulations. Legalization has increased the reporting of adverse effects that are not well studied and contributes to the growing need for uniform research. Identification of unclear regulations is resulting in new recommendations and bills to assign responsibility to standardize enactment and enforcement of the law as well as mitigate the potential threat of federal prosecution and loss of human rights.

The primary problem addressed by Act 16 includes the ability to access the latest treatments that can improve patient pain and suffering when traditional treatment options are ineffective or unsatisfactory. Act 16 also provides regulations relating to marijuana growth, processing, and distribution, as well as patient safety. The Act specifies fees and allocation of funding to support and enforce these regulations, and to provide resources for further research.

This article will discuss: current policy goals, listed medical conditions, major interest groups, ethical interests, policy outcomes, and global comparisons.

SKU: 193091 Category:

Description

Pennsylvania’s Medical Marijuana Act legalized the use of medical marijuana as an alternative therapeutic to ease suffering and improve the quality of life in patients who are terminally ill or suffer from a serious medical condition. Lack of valid and reliable research has inhibited the development of evidence-based recommendations. There are ethical concerns regarding generated financial revenue, consumer access, and safety. Legal conflict exists with federal statutes impacting all stages of growth, processing, distribution, and use, as well as enforcement, banking, and employment regulations. Legalization has increased the reporting of adverse effects that are not well studied and contributes to the growing need for uniform research. Identification of unclear regulations is resulting in new recommendations and bills to assign responsibility to standardize enactment and enforcement of the law as well as mitigate the potential threat of federal prosecution and loss of human rights.

Reviews

There are no reviews yet.

Be the first to review “Medical Marijuana in Pennsylvania | 1.1 contact hour”

Your email address will not be published. Required fields are marked *